Request an appointment or second opinion with the Fertility Center or refer a patient.
Explore infertility research at the Massachusetts General Hospital Fertility Center and search open clinical trials and medical studies.
The Vincent Center for Reproductive Biology consists of basic and clinical scientists whose primary research emphasis includes infertility, aging and cancer as they pertain to the ovary and uterus. The center provides an optimal environment for individuals who are interested in integrating clinical and basic sciences and have a strong desire to pursue a career in academic research.
Search for clinical trials and research studies currently seeking participants.
The START Study tracks women’s mood symptoms throughout infertility treatment cycles. Study participants include women with a history of major depression or bipolar depression currently in remission who are planning or are under going infertility treatment. (Ongoing but not enrolling)
Advances in Motion highlights the latest breakthroughs, research and clinical trials from Mass General.
Our program trains OB/GYN subspecialists to manage complex infertility and reproductive endocrinology issues with an emphasis on research.
The Department of Obstetrics and Gynecology at Mass General has advanced the science and the quality of care for patients since 1891.
The Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital (MGH) awards the 2024 Gupta Family Endowed Prize for Innovation in ALS Care.
The Sean. M. Healey & AMG Center for ALS at Massachusetts General Hospital through the generosity of Drs. Shelena and Ayeez Lalji, is delighted to announce the 2nd annual Drs. Ayeez and Shelena Lalji & Family Student Scholar for Repair and Regenerative Mechanisms in ALS.
Francisco Flores, PhD, is lead author of a recently published paper in Techniques and Methods; Electrographic Seizures During Low-Current Thalamic Deep Brain Stimulation in Mice
National Institute of Allergy and Infectious Diseases and Mass General Hospital researchers’ ability to optimize gene editing in stem cells could provide blueprint for treatment of other rare diseases
Data from the REPRIEVE trial suggest there is only a minimal increased risk of diabetes with statins among people with HIV, and in specific, limited groups
Nabeel Bardeesy, PhD, is senior author of a new study in Cancer Discovery, DNAJB1-PRKACA Fusion Drives Fibrolamellar Liver Cancer Through Impaired SIK Signaling and CRTC2/p300-mediated Transcriptional Reprogramming.
OB/GYN Advances is an update for health care professionals from specialists at Massachusetts General Hospital on research and clinical advances in obstetrics and gynecology.
